Cargando…
Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathy
Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited sensory and motor peripheral neuropathy. It is caused by PMP22 overexpression which leads to defects of peripheral myelination, loss of long axons, and progressive impairment then disability. There is no treatment available des...
Autores principales: | Chumakov, Ilya, Milet, Aude, Cholet, Nathalie, Primas, Gwenaël, Boucard, Aurélie, Pereira, Yannick, Graudens, Esther, Mandel, Jonas, Laffaire, Julien, Foucquier, Julie, Glibert, Fabrice, Bertrand, Viviane, Nave, Klaus-Armin, Sereda, Michael W, Vial, Emmanuel, Guedj, Mickaël, Hajj, Rodolphe, Nabirotchkin, Serguei, Cohen, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279797/ https://www.ncbi.nlm.nih.gov/pubmed/25491744 http://dx.doi.org/10.1186/s13023-014-0201-x |
Ejemplares similares
-
Early short-term PXT3003 combinational therapy delays disease onset in a transgenic rat model of Charcot-Marie-Tooth disease 1A (CMT1A)
por: Prukop, Thomas, et al.
Publicado: (2019) -
Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson’s disease
por: Hajj, Rodolphe, et al.
Publicado: (2015) -
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy
por: Chumakov, Ilya, et al.
Publicado: (2015) -
An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
por: Attarian, Shahram, et al.
Publicado: (2014) -
Erratum to: An exploratory randomised double-blind and placebo-controlled phase 2 study of a combination of baclofen, naltrexone and sorbitol (PXT3003) in patients with Charcot-Marie-Tooth disease type 1A
por: Attarian, Shahram, et al.
Publicado: (2016)